{"indicator":"3.b.3","layout":"indicator","permalink":"/3-b-3/","sdg_goal":"3","target_id":"3.b","published":true,"target_name":"\uac1c\ub3c4\uad6d\uc5d0\uc11c \uc8fc\ub85c \ubc1c\uc0dd\ud558\ub294 \uc804\uc5fc\uc131 \ubc0f \ube44\uc804\uc5fc\uc131 \uc9c8\ubcd1\uc5d0 \ub300\ud55c \ubc31\uc2e0 \ubc0f \uc57d\ud488 \uac1c\ubc1c\uacfc \uc5f0\uad6c \uc9c0\uc6d0, \uc800\ub834\ud55c \uac00\uaca9\uc758 \ud544\uc218 \uc758\uc57d\ud488 \ubc0f \ubc31\uc2e0\uc758 \uc81c\uacf5, \ud2b9\ud788 \ubaa8\ub450\uc5d0\uac8c \uc758\uc57d\ud488\uc5d0 \ub300\ud55c \uc811\uadfc\uc744 \ubcf4\uc7a5","computation_definitions":"<b> \ub370\uc774\ud130 \uc774\uc6a9 \uc81c\ud55c(4\uc720\ud615) </b>   <br> \ud604\uc7ac \uc774\uc6a9\ud560 \uc218 \uc788\ub294 \uad6d\ub0b4\ud1b5\uacc4, \uad6d\uc81c\uae30\uad6c\ud1b5\uacc4, \uad6d\ub0b4\uc720\uc0ac\ud1b5\uacc4\uac00 \uc5c6\uc2b5\ub2c8\ub2e4.  <br>  1\uc720\ud615, 2\uc720\ud615, 3\uc720\ud615\uc5d0 \uc18d\ud558\ub098 \uc77c\uc2dc\uc801\uc73c\ub85c \uc11c\ube44\uc2a4\uac00 \ub418\uc9c0 \uc54a\ub294 \uacbd\uc6b0\ub3c4 \ud3ec\ud568\ub429\ub2c8\ub2e4.","indicator_name":"Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis","indicator_definition":"\uc870\uc0ac\ub300\uc0c1 \uc804\uccb4 \uc758\ub8cc\uc2dc\uc124 \uc911 \ud488\uc9c8\uc774 \ubcf4\uc99d\ub41c \ud575\uc2ec \ud544\uc218 \uc758\uc57d\ud488\uc744 \uc801\ub2f9\ud55c \uac00\uaca9\uc73c\ub85c \uad6c\uc785\ud560 \uc218 \uc788\ub294 \uc758\ub8cc\uc2dc\uc124\uc758 \ube44\uc728\ub85c\uc11c \ub2e4\ucc28\uc6d0 \ubcf5\ud569 \uc9c0\uc218\ub85c \uc791\uc131\ub428","global_indicator_name":"\uc801\uc815\ud55c \uac00\uaca9\uc73c\ub85c \ud544\uc218 \uc758\uc57d\ud488\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \uad6c\uc785\ud560 \uc218 \uc788\ub294 \uc758\ub8cc\uc2dc\uc124 \ube44\uc728","un_designated_tier":"III","un_custodian_agency":"WHO","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-03.pdf","goal_meta_link_text":"UN Metadata","goal_meta_local_link":"https://kostat-sdg-kor.github.io/sdg-indicators/public/data/Metadata-03-0b-03_KOR.pdf","goal_meta_local_link_text":"https://kostat-sdg-kor.github.io/sdg-indicators/public/data/Metadata-03-0b-03_KOR.pdf","reporting_status":"notapplicable","data_non_statistical":false,"graph_type":"line","source_active_1":false,"source_organisation_1":"World Health Organisation (WHO)","source_active_2":false,"source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"indicator_sort_order":"03-bb-03","data_show_map":false,"source_url_text_1":"Link to Source","source_url_text_2":"Link to Source","source_url_3":"Link to Source","source_url_text_4":"Link to source","source_url_text_5":"Link to source","source_url_text_6":"Link to source","source_active_7":false,"source_url_text_7":"Link to source","source_active_8":false,"source_url_text_8":"Link to source","source_active_9":false,"source_url_text_9":"Link to source","title":"Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis","page_content":"\u25b6 Data unavailable: There are currently no national statistics (Type 1), international statistics (Type 2), or alternative national statistics (Type 3) available. The Data of Type 1, type 2, or type 3 can be also included in case of temporary unavailability.\n","graph_title":"\uc801\uc815\ud55c \uac00\uaca9\uc73c\ub85c \ud544\uc218 \uc758\uc57d\ud488\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \uad6c\uc785\ud560 \uc218 \uc788\ub294 \uc758\ub8cc\uc2dc\uc124 \ube44\uc728","un_sd_indicator_code":"C030b03","un_notes":"UNSC 48 Refinement; Reviewed at 5th IAEG-SDG meeting","target":"Support the research and development of vaccines and medicines for the communicable and non\u2011communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","national_metadata":"","global_metadata":"https://unstats.un.org/sdgs/tierIII-indicators/","global_metadata_text":"https://unstats.un.org/sdgs/tierIII-indicators/"}